Long-Term Outcomes of Treatment with Biological Agents in Eyes with Refractory, Active, Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.
Ophthalmology
; 127(3): 410-416, 2020 03.
Article
in En
| MEDLINE
| ID: mdl-31607412
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biological Factors
/
Panuveitis
/
Uveitis, Intermediate
/
Uveitis, Posterior
/
Adalimumab
/
Infliximab
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ophthalmology
Year:
2020
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United States